GlassScriptPhysician profile
Abdullah Siddiqui
NPI 1598184459
$2,035.29
in general payments reported to CMS, 2019-2025
13 companies · $383 in 2025
The $383 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $994 · 2021: $262 · 2022: $68.05 · 2023: $328 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,167.20 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $219.31 | 2019-2025 | Mounjaro, Zepbound, Taltz |
| Dexcom, INC. | $217.28 | 2023-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Abbott Laboratories | $136.39 | 2021-2025 | Freestyle Libre 3 |
| Medtronic, INC. | $95.55 | 2023 | Inpen Smart Insulin Delivery System |
| Cequr Corporation | $47.94 | 2025 | Cequr Simplicity |
| Astrazeneca Pharmaceuticals LP | $33.19 | 2021 | |
| Tandem Diabetes Care, INC. | $27.87 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Recordati_rare_diseases_inc. | $24.12 | 2025 | Isturisa |
| Janssen Pharmaceuticals, INC | $23.59 | 2019 | |
| Exact Sciences Corporation | $16.20 | 2025 | Cologuard Collection Kit |
| Nevro Corp. | $15.41 | 2023 | Senza |
| Beta Bionics, INC. | $11.24 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdullah Siddiqui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.